We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
101
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$308K 0.07%
566
-21
-4% -$11K
IBM icon
102
IBM
IBM
$222B
$305K 0.07%
1,766
+1
+0.1% +$174
VICI icon
103
VICI Properties
VICI
$28.5B
$303K 0.07%
10,569
– –
EFA icon
104
iShares MSCI EAFE ETF
EFA
$79.6B
$297K 0.07%
3,788
-13
-0.3% -$1.03K
RSG icon
105
Republic Services
RSG
$68B
$294K 0.07%
1,512
– –
VRTX icon
106
Vertex Pharmaceuticals
VRTX
$137B
$293K 0.07%
625
+100
+19% +$43.4K
CVS icon
107
CVS Health
CVS
$119B
$291K 0.07%
4,923
-143,553
-97% -$8.98M
PNC icon
108
PNC Financial Services
PNC
$96.6B
$288K 0.07%
1,853
+1
+0.1% +$155
EMR icon
109
Emerson Electric
EMR
$86.6B
$286K 0.07%
2,594
+1,750
+207% +$193K
ESS icon
110
Essex Property Trust
ESS
$18.3B
$276K 0.07%
1,014
+52
+5% +$13.3K
MDT icon
111
Medtronic
MDT
$117B
$274K 0.07%
3,480
-89
-2% -$7.3K
ED icon
112
Consolidated Edison
ED
$39.8B
$271K 0.06%
3,034
– –
IWD icon
113
iShares Russell 1000 Value ETF
IWD
$84.3B
$268K 0.06%
1,534
-62
-4% -$10.8K
FPE icon
114
First Trust Preferred Securities and Income ETF
FPE
$6.3B
$266K 0.06%
15,302
-33
-0.2% -$569
GS icon
115
Goldman Sachs
GS
$301B
$262K 0.06%
580
– –
DUK icon
116
Duke Energy
DUK
$93.8B
$256K 0.06%
2,557
– –
VONG icon
117
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$252K 0.06%
2,683
– –
ZTS icon
118
Zoetis
ZTS
$32B
$250K 0.06%
1,440
– –
NVS icon
119
Novartis
NVS
$292B
$238K 0.06%
2,233
-1,075
-32% -$108K
WFC icon
120
Wells Fargo
WFC
$262B
$235K 0.06%
3,962
+8
+0.2% +$472
WM icon
121
Waste Management
WM
$87.8B
$231K 0.06%
1,081
– –
BMY icon
122
Bristol-Myers Squibb
BMY
$136B
$230K 0.05%
5,546
-89
-2% -$3.98K
PH icon
123
Parker-Hannifin
PH
$125B
$229K 0.05%
453
+10
+2% +$5.36K
ORCL icon
124
Oracle
ORCL
$435B
$224K 0.05%
1,584
– –
INTC icon
125
Intel
INTC
$473B
$218K 0.05%
7,050
-100
-1% -$3.28K
3 4
5
6 7

Similar funds

EDRIA
Edmonds Duncan Registered Investment Advisors Lawrence, Kansas $457M AUM 23% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
AC
Albar Capital London, United Kingdom $445M AUM 55.79% 1-Year Est. Return
NIC
Northwest Investment Counselors Lake Oswego, Oregon $442M AUM 29.9% 1-Year Est. Return
WCA
Waypoint Capital Advisors Minneapolis, Minnesota $470M AUM 32.8% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
FPFS
First Personal Financial Services Charlotte, North Carolina $473M AUM 28.33% 1-Year Est. Return

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.